EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 11.08.2026 / 08:00 CET/CEST Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed: Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: August 25, 2026 Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/ Language: English Date of disclosure: August 25, 2026 Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/ 11.08.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News

Language:	English
Company:	Dermapharm Holding SE
	Lil-Dagover-Ring 7
	82031 Grünwald
	Germany
Internet:	ir.dermapharm.de
LEI Code:	5299009F0KNZINQQQK37

End of News	EQS News Service

2376924  11.08.2026 CET/CEST